Modern healthcare is fragmented. Understanding your condition helps connect the dots.

0

Your Cart is Empty

Library

Migraine Patient’s Guide — References

This page lists the academic and web-based sources that informed the Migraine Patient’s Guide. It is provided for those who wish to review the references used within the guide.

Web Resources:

Academic References:

  • Science of Migraine, 2023. Phases of Migraine. Available at: https://www.scienceofmigraine.com/pathophysiology/phases-of-migraine [Accessed 6 Nov. 2024].
  • The Journal of Headache and Pain, 2022. Thalamic hyperactivity and sensory sensitivity in migraine. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-022-01491-z [Accessed 6 Nov. 2024].
  • Wells, R.E., O’Connell, N., Pierce, C.R., Estave, P.M., Penzien, D.B., Loder, E., Houle, T.T., and Zeidan, F., 2020. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. JAMA Internal Medicine, 180(3), pp. 317–325. Available at: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774130 [Accessed 6 Nov. 2024].
  • Simshäuser, K., Pohl, R., Behrens, P., Schultz, C., Lahmann, C., and Schmidt, S., 2021. Mindfulness-Based Cognitive Therapy as Migraine Intervention: a Randomized Waitlist Controlled Trial. International Journal of Behavioral Medicine, 29(3), pp. 597–609. Available at: https://link.springer.com/article/10.1007/s12529-021-10044-8 [Accessed 6 Nov. 2024].
  • John, P.J., Sharma, N., Sharma, C.M., and Kankane, A., 2007. Effectiveness of Yoga Therapy in the Treatment of Migraine Without Aura: A Randomized Controlled Trial. Headache: The Journal of Head and Face Pain, 47(5), pp.654-661. Available at: https://www.academia.edu/30520379/Effectiveness_of_Yoga_Therapy_in_the_Treatment_of_Migraine_Without_Aura_A_Randomized_Controlled_Trial [Accessed 6 Nov. 2024].
  • Kisan, R., Sujan, M.U., Adoor, M., Rao, R., Nalini, A., Kutty, B.M., Murthy, B.T.C., and Sathyaprabha, T.N., 2014. Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions. International Journal of Yoga, 7(2), pp.126-132. Available at: https://europepmc.org/article/MED/25035622 [Accessed 6 Nov. 2024].
  • Li, Y., Zheng, H., Witt, C.M., Roll, S., Yu, S., Yan, J., Sun, G., Zhao, L., Chang, X., Shang, H., and Bian, Z., 2012. Acupuncture for migraine prophylaxis: a randomized controlled trial. JAMA Internal Medicine, 172(4), pp. 401–410. Available at: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2603492 [Accessed 6 Nov. 2024].
  • Linde, K., Allais, G., Brinkhaus, B., Fei, Y., Mehring, M., Shin, B.C., Vickers, A., and White, A.R., 2016. Acupuncture for the prevention of episodic migraine. Cochrane Database of Systematic Reviews, (6), CD001218. Available at: https://www.cochrane.org/CD001218/SYMPT_acupuncture-preventing-migraine-attacks [Accessed 6 Nov. 2024].
  • Zhang, N., Houle, T., Hindiyeh, N., and Aurora, S.K., 2020. Systematic Review: Acupuncture vs Standard Pharmacological Therapy for Migraine Prevention. Headache: The Journal of Head and Face Pain, 60(2), pp.309-317. Available at: https://research.pingminghealth.com/article/240/ [Accessed 6 Nov. 2024].
  • Pittler, M.H. and Ernst, E., 2004. Feverfew for preventing migraine. Cochrane Database of Systematic Reviews, (1), CD002286. Available at: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002286.pub2/abstract [Accessed 6 Nov. 2024].
  • Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R.T., and Mullin, G.E., 2019. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complementary and Alternative Medicine, 19(1), p.21. Available at: https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-018-2409-0 [Accessed 6 Nov. 2024].
  • Ford, A.C., Talley, N.J., Spiegel, B.M.R., Foxx-Orenstein, A.E., Schiller, L., Quigley, E.M.M., and Moayyedi, P., 2008. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ, 337, a2313. Available at: https://www.bmj.com/content/337/bmj.a2313 [Accessed 6 Nov. 2024].
  • Allais, G., D’Andrea, G., Maggio, M., and Benedetto, C., 2013. The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial. Neurological Sciences, 34(Suppl 1), pp.S161–S163. Available at: https://link.springer.com/article/10.1007/s10072-013-1413-x [Accessed 6 Nov. 2024].
  • Duke University, 2024. The impact of spinal manipulation on migraine pain and disability: A systematic review and meta-analysis. Available at: https://sites.duke.edu/cemmt/the-impact-of-spinal-manipulation-on-migraine-pain-and-disability-a-systematic-review-and-meta-analysis-2/ [Accessed 6 Nov. 2024].
  • The Journal of Headache and Pain, 2011. Manual therapies for migraine: a systematic review. The Journal of Headache and Pain, 12(2), pp.127-133. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1007/s10194-011-0296-6 [Accessed 6 Nov. 2024].
  • Chaibi, A., Benth, J.Š., Tuchin, P.J., and Russell, M.B., 2017. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. European Journal of Neurology, 24(1), pp.143-153. Available at: https://onlinelibrary.wiley.com/doi/full/10.1111/ene.13166 [Accessed 6 Nov. 2024].
  • Chaibi, A., Tuchin, P.J., and Russell, M.B., 2011. Manual therapies for migraine: a systematic review. The Journal of Headache and Pain, 12(2), pp.127-133. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1007/s10194-011-0296-6 [Accessed 6 Nov. 2024].
  • Luedtke, K., Starke, W., and May, A., 2018. Musculoskeletal dysfunction in migraine patients. Cephalalgia, 38(5), pp.865-875. Available at: https://journals.sagepub.com/doi/10.1177/0333102417716934 [Accessed 6 Nov. 2024].
  • Bevilaqua-Grossi, D., Gonçalves, M.C., Carvalho, G.F., Florencio, L.L., Dach, F., and Speciali, J.G., 2016. Additional effects of a physical therapy protocol on headache frequency, pressure pain threshold, and improvement perception in patients with migraine and associated neck pain: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation, 97(6), pp.866-874. Available at: https://www.archives-pmr.org/article/S0003-9993(15)01558-0/fulltext [Accessed 6 Nov. 2024].
  • Arnadottir, T.S. and Sigurdardottir, A.K., 2013. Is craniosacral therapy effective for migraine? Tested with HIT-6 questionnaire. Complementary Therapies in Clinical Practice, 19(1), pp.11-14. Available at: https://www.degruyter.com/document/doi/10.7556/jaoa.2017.011/html [Accessed 6 Nov. 2024].
  • Ferracini, G.N., Chaves, T.C., Dach, F., Bevilaqua-Grossi, D., Fernández-de-Las-Peñas, C., and Speciali, J.G., 2016. Relationship Between Active Trigger Points and Head/Neck Posture in Patients with Migraine. American Journal of Physical Medicine & Rehabilitation, 95(11), pp.831-839. Available at: https://journals.lww.com/ajpmr/Abstract/2016/11000/Relationship_Between_Active_Trigger_Points_and.6.aspx [Accessed 6 Nov. 2024].
  • Chiu, H.Y., Yeh, T.H., Huang, Y.C., and Chen, P.Y., 2016. Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain Physician, 19(1), pp.E97-E112. Available at: https://www.painphysicianjournal.com/current/pdf?article=MjQ4Nw%3D%3D&journal=93 [Accessed 6 Nov. 2024].
  • Schoenen, J., Jacquy, J., and Lenaerts, M., 1998. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology, 50(2), pp.466-470. Available at: https://n.neurology.org/content/50/2/466 [Accessed 6 Nov. 2024].
  • Sazali, S., Badrin, S., Norhayati, M.N., and Idris, N.S., 2021. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine—a meta-analysis. BMJ Open, 11(1), e039358. Available at: https://bmjopen.bmj.com/content/11/1/e039358 [Accessed 6 Nov. 2024].
  • Shoeibi, A., Olfati, N., Soltani, S., and Kazemnejad, E., 2017. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta Neurologica Belgica, 117(1), pp.103-109. Available at: https://link.springer.com/article/10.1007/s13760-016-0697-z [Accessed 6 Nov. 2024].
  • Ramsden, C.E., Faurot, K.R., Zamora, D., Suchindran, C.M., Macintosh, B.A., Gaylord, S., Ringel, A., Hibbeln, J.R., and Feldstein, A.E., 2013. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. The Journal of Pain, 14(5), pp.476-486. Available at: https://www.jpain.org/article/S1526-5900(13)00527-0/fulltext [Accessed 6 Nov. 2024].
  • Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z.S., Rasekh Magham, R., Haghighi, S., Djalali, M., Zareei, M., Razeghi Jahromi, S., Shahemi, S., and Mahmoudi, M., 2020. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. The Journal of Headache and Pain, 21(1), p.22. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-01090-w [Accessed 6 Nov. 2024].
  • Zandifar, A., Masjedi, S.S., Banihashemi, M., Asgari, F., Manouchehri, N., Ebrahimi, H., and Saadatnia, M., 2014. Vitamin D status in migraine patients: a case-control study. BioMed Research International, 2014, Article ID 514782. Available at: https://www.hindawi.com/journals/bmri/2014/514782/ [Accessed 6 Nov. 2024].
  • Simko, F. and Paulis, L., 2007. Melatonin as a potential antihypertensive treatment. Journal of Pineal Research, 42(4), pp.319-322. Available at: https://onlinelibrary.wiley.com/doi/10.1111/j.1600-079X.2007.00436.x [Accessed 6 Nov. 2024].
  • Ahmadi, H., Mazloumi-Kiapey, S.S., Sadeghi, O., Nasiri, M., Khorvash, F., Mottaghi, T., and Askari, G., 2020. Zinc supplementation affects favorably the frequency of migraine attacks: a double-blind randomized placebo-controlled clinical trial. Nutrition Journal, 19(1), p.101. Available at: https://nutritionj.biomedcentral.com/articles/10.1186/s12937-020-00618-9 [Accessed 6 Nov. 2024].
  • Menon, S., Lea, R.A., Roy, B., Hanna, M., Wee, S., Haupt, L.M., Oliver, C., and Griffiths, L.R., 2012. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenetics and Genomics, 22(10), pp.741-749. Available at: https://journals.lww.com/jpharmacogenetics/Abstract/2012/10000/Genotypes_of_the_MTHFR_C677T_and_MTRR_A66G_genes.5.aspx [Accessed 6 Nov. 2024].
  • Lea, R., Colson, N., Quinlan, S., Macmillan, J., and Griffiths, L., 2009. The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability. Pharmacogenetics and Genomics, 19(6), pp.422-428. Available at: https://journals.lww.com/jpharmacogenetics/Abstract/2009/06000/The_effects_of_vitamin_supplementation_and_MTHFR.5.aspx [Accessed 6 Nov. 2024].
  • Marangon, K., Devaraj, S., Tirosh, O., Packer, L., and Jialal, I., 2007. Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radical Biology and Medicine, 43(4), pp. 1398-1404. Available at: https://pubmed.ncbi.nlm.nih.gov/17284733/ [Accessed 6 Nov. 2024].
  • Grangeon, L., Lange, K.S., Waliszewska-Prosół, M., Onan, D., Marschollek, K., Wiels, W., Mikulenka, P., Farham, F., Gollion, C., and Ducros, A., 2023. Genetics of migraine: where are we now? The Journal of Headache and Pain, 24(1), p.12. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-023-01547-8 [Accessed 6 Nov. 2024].
  • Corominas, R., Ribases, M., Camiña, M., Cuenca-León, E., Pardo, J., Boronat, S., Sobrido, M.J., Cormand, B., and Macaya, A., 2009. Two-stage case-control association study of dopamine-related genes and migraine. BMC Medical Genetics, 10, p.95. Available at: https://bmcmedgenet.biomedcentral.com/articles/10.1186/1471-2350-10-95 [Accessed 6 Nov. 2024].
  • Sokolov, A.Y., Lyubashina, O.A., and Panteleev, S.S., 2011. The role of serotonin receptors in migraine headaches. Neurochemical Journal, 5(2), pp.92-99. Available at: https://link.springer.com/article/10.1134/S1819712411020085 [Accessed 6 Nov. 2024].
  • Zandifar, A., Haghdoost, F., Zandifar, M., and Saadatnia, M., 2014. Anxiety and depression in migraine patients and their relation with severity, frequency, and impact of headaches. The Journal of Headache and Pain, 15(Suppl 1), p.D76. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/1129-2377-15-S1-D76 [Accessed 6 Nov. 2024].
  • Breslau, N., Lipton, R.B., Stewart, W.F., Schultz, L.R., and Welch, K.M.A., 2003. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology, 60(8), pp.1308-1312. Available at: https://n.neurology.org/content/60/8/1308 [Accessed 6 Nov. 2024].
  • Todor, T.S. and Fukudo, S., 2023. Systematic review and meta-analysis of calculating degree of comorbidity of irritable bowel syndrome with migraine. BioPsychoSocial Medicine, 17(1), p.22. Available at: https://bpsmedicine.biomedcentral.com/articles/10.1186/s13030-023-00275-4 [Accessed 6 Nov. 2024].
  • Oh, K., Cho, S.J., Chung, Y.K., Kim, J.M., and Chu, M.K., 2014. Combination of anxiety and depression is associated with an increased headache frequency in migraineurs: a population-based study. BMC Neurology, 14, p.238. Available at: https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-014-0238-4 [Accessed 6 Nov. 2024].
  • Kurth, T., Rist, P.M., Ridker, P.M., and Buring, J.E., 2018. Migraine, headache, and the risk of cardiovascular disease in women: a prospective cohort study. BMJ, 360, k275. Available at: https://www.bmj.com/content/360/bmj.k275 [Accessed 6 Nov. 2024].
  • Kardes, G., Hadimli, A., and Ergenoglu, A.M., 2024. Hormonal changes and migraine frequency in pregnancy. Journal of Obstetric Neurology, 19(5), pp.154-160. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10379615/ [Accessed 6 Nov. 2024].
  • Källén, B., Lygner, P.E., and Mottet, I., 2011. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Safety, 34(8), pp.691-703. Available at: https://pubmed.ncbi.nlm.nih.gov/21751829/ [Accessed 6 Nov. 2024].
  • Cunnington, M., Ephross, S., Marshall, S., and Kruesi, M., 2009. The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache, 49(10), pp.1414-1422. Available at: https://pubmed.ncbi.nlm.nih.gov/19804390/ [Accessed 6 Nov. 2024].
  • Harriott, A.M., Kaya, M., and Ayata, C., 2024. Oxytocin shortens spreading depolarization-induced periorbital allodynia. The Journal of Headache and Pain, 25(1), p.152. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01855-7 [Accessed 6 Nov. 2024].
  • Haghdoost, F. and Togha, M., 2022. Migraine management: Non-pharmacological points for patients and health care professionals. Open Medicine, 17(1), pp.1869–1882. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9691984/ [Accessed 6 Nov. 2024].
  • Mackey, S., Gilam, G., Darnall, B., Goldin, P., Kong, J.T., Law, C., Heirich, M., Karayannis, N., Kao, M.C., Tian, L., Manber, R., and Gross, J., 2022. Mindfulness-Based Stress Reduction, Cognitive Behavioral Therapy, and Acupuncture in Chronic Low Back Pain: Protocol for Two Linked Randomized Controlled Trials. JMIR Research Protocols, 11(9), p.e37823. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9555327/ [Accessed 6 Nov. 2024].
  • Maghbooli, M., Golipour, F., Moghimi Esfandabadi, A., and Yousefi, M., 2013. Comparison Between the Efficacy of Ginger and Sumatriptan in the Ablative Treatment of the Common Migraine. Journal of Research in Medical Sciences, 18(6), pp. 493–497. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790900/ [Accessed 6 Nov. 2024].
  • Rezaie, S., Askari, G., Khorvash, F., Tarrahi, M.J., and Amani, R., 2021. Effects of Curcumin Supplementation on Clinical Features and Inflammation in Migraine Patients: A Double-Blind Controlled, Placebo Randomized Clinical Trial. International Journal of Preventive Medicine, 12, p.161. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8724631/ [Accessed 6 Nov. 2024].
  • Chaibi, A. and Tuchin, P.J., 2011. Chiropractic spinal manipulative treatment of migraine headache of 40-year duration using Gonstead method: a case study. Journal of Chiropractic Medicine, 10(3), pp.189-193. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259914/ [Accessed 6 Nov. 2024].
  • Rist, P.M., Hernandez, A., Bernstein, C., Kowalski, M., Osypiuk, K., Vining, R., Long, C.R., Goertz, C., Song, R., and Wayne, P.M., 2019. The impact of spinal manipulation on migraine pain and disability: A systematic review and meta-analysis. Headache, 59(4), pp.532-542. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461372/ [Accessed 6 Nov. 2024].
  • Chaibi, A., Benth, J.Š., Tuchin, P.J., and Russell, M.B., 2017. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. European Journal of Neurology, 24(1), pp.143-153. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214068/ [Accessed 6 Nov. 2024].
  • Gonçalves, A.L., Martini Ferreira, A.P., Ribeiro, R.T., Zukerman, E., and Cipolla-Neto, J., 2016. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. Journal of Neurology, Neurosurgery & Psychiatry, 87(10), pp.1127-1132. Available at: https://jnnp.bmj.com/content/87/10/1127 [Accessed 6 Nov. 2024].
  • Ebrahimi-Monfared, M., Sharafkhah, M., Abdolrazaghnejad, A., and Ghaderi, E., 2022. Melatonin as a treatment for migraine sufferers: a systematic review and meta-analysis of randomized controlled trials. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 58(1), p.19. Available at: https://ejnpn.springeropen.com/articles/10.1186/s41983-022-00524-3 [Accessed 6 Nov. 2024].
  • Rezaei Kelishadi, M., Alavi Naeini, A., Askari, G., Khorvash, F., and Heidari, Z., 2021. The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial. International Journal of Clinical Practice, 75(9), e14455. Available at: https://europepmc.org/article/MED/34105866 [Accessed 6 Nov. 2024].
  • National Headache Foundation, n.d. Biofeedback and Relaxation Training for Headaches. Available at: https://americanmigrainefoundation.org/resource-library/biofeedback-and-relaxation-training/ [Accessed 6 Nov. 2024].
  • The Migraine Trust, n.d. Genetics and migraine. Available at: https://migrainetrust.org/understand-migraine/genetics-and-migraine/ [Accessed 6 Nov. 2024].
  • American Migraine Foundation, 2017. The Genetics of Migraine. Available at: https://americanmigrainefoundation.org/resource-library/genetics-of-migraine/ [Accessed 6 Nov. 2024].
  • Gormley, P., Anttila, V., Winsvold, B.S., Palta, P., Esko, T., Pers, T.H., Farh, K.H., Cuenca-Leon, E., Muona, M., Furlotte, N.A., Kurth, T., Ingason, A., McMahon, G., Ligthart, L., Terwindt, G.M., Koiranen, M., Quaye, L., Adams, H.H., Lehtimäki, T., Sarin, A.P., Wedenoja, J., Hinds, D.A., Buring, J.E., Schürks, M., Hrafnsdottir, M.G., Stefansson, H., Ring, S.M., Hottenga, J.J., Penninx, B.W., Spector, T., Wessman, M., Artto, V., Kaunisto, M.A., Vepsäläinen, S., Malik, R., Heath, A.C., Madden, P.A., Martin, N.G., Montgomery, G.W., Kurki, M.I., Kals, M., Mägi, R., Pärna, K., Hämäläinen, E., Huang, H., Huang, J., Sandor, C., Webber, C., Muller-Myhsok, B., Schreiber, S., Meitinger, T., Eriksson, J.G., Salomaa, V., Heikkilä, K., Loehrer, E., Uitterlinden, A.G., Hofman, A., van Duijn, C.M., Cherkas, L., Pedersen, L.M., Stubhaug, A., Nielsen, C.S., Männikkö, M., Mihailov, E., Milani, L., Göbel, H., Esserlind, A.L., Christensen, A.F., Hansen, T.F., Werge, T., Kaprio, J., Aromaa, A.J., Raitakari, O., Ikram, M.A., Stolk, L., Hämäläinen, M.S., Koskenvuo, M., Zwart, J.A., Boomsma, D.I., Erikstrup, C., Olesen, J., Chasman, D.I., Nyholt, D.R., Binder, A., Dichgans, M., Kubisch, C., Ferrari, M.D., Belin, A.C., van den Maagdenberg, A.M., Zilbauer, M., Järvelin, M.R., Metspalu, A., Kubitza, D., Ripke, S., Cader, M.Z., Stefansson, K., Daly, M.J., Neale, B.M., and Palotie, A., 2016. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nature Genetics, 48(8), pp.856-866. Available at: https://www.nature.com/articles/ng.3598 [Accessed 6 Nov. 2024].
  • Hautakangas, H., Winsvold, B.S., Ruotsalainen, S.E., Bjornsdottir, G., Harder, A.V.E., Kogelman, L.J.A., Thomas, L.F., Noordam, R., Benner, C., Willer, C.J., Zwart, J.A., Palotie, A., and Ripke, S., 2022. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nature Genetics, 54(2), pp.152-160. Available at: https://www.nature.com/articles/s41588-021-00990-0 [Accessed 6 Nov. 2024].
  • An, Y.-C., Hung, K.-S., Liang, C.-S., Tsai, C.-K., Tsai, C.-L., Chen, S.-J., Lin, Y.-K., Lin, G.-Y., Yeh, P.-K., and Yang, F.-C., 2024. Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population. The Journal of Headache and Pain, 25(1), p.149. Available at: https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01850-y [Accessed 6 Nov. 2024].
  • Tsirelis, D., Tsekouras, A., Stamati, P., Liampas, I., Zoupa, E., Dastamani, M., Tsouris, Z., Papadimitriou, A., Dardiotis, E., and Siokas, V., 2024. The impact of genetic factors on the response to migraine therapy. Reviews in the Neurosciences, 35(4), pp.445-458. Available at: https://www.degruyter.com/document/doi/10.1515/revneuro-2024-0045/html [Accessed 6 Nov. 2024].
  • Minen, M.T., Begasse De Dhaem, O., Kroon Van Diest, A., Powers, S., Schwedt, T.J., Lipton, R., and Silbersweig, D., 2016. Migraine and its psychiatric comorbidities. Journal of Neurology, Neurosurgery & Psychiatry, 87(7), pp.741-749. Available at: https://jnnp.bmj.com/content/87/7/741 [Accessed 6 Nov. 2024].
  • American Migraine Foundation, n.d. Sleep, Insomnia and Migraine. Available at: https://americanmigrainefoundation.org/resource-library/sleep-insomnia-migraine/ [Accessed 6 Nov. 2024].
  • Wang, X., Zhou, H., Sun, Q., and Yang, Y., 2021. Association Between Asthma and Migraine: A Systematic Review and Meta-Analysis of Cohort Studies. Frontiers in Allergy, 2, p.741135. Available at: https://www.frontiersin.org/articles/10.3389/falgy.2021.741135/full [Accessed 6 Nov. 2024].
  • American Migraine Foundation, n.d. Comorbidities of Migraine. Available at: https://americanmigrainefoundation.org/resource-library/comorbidities-of-migraine/ [Accessed 6 Nov. 2024].
  • Melbourne Headache Neck & Jaw Clinic. (2024). Migraine Supplements - Curcumin. Available at: https://melbourneheadacheneckjaw.com.au/blog/f/migraine-supplements---curcumin [Accessed 20 November 2024].
  • NutraIngredients-Asia. (2021). Omega-3, nanocurcumin reduce migraine attacks by working at the gene level: Two-month RCT. Available at: https://www.nutraingredients-asia.com/Article/2021/09/14/Omega-3-nanocurcumin-reduce-migraine-attacks-by-working-at-the-gene-level-Two-month-RCT [Accessed 20 November 2024].